Cited by 211Cancer, Hypoxia, and MetabolismAdenosine and Purinergic SignalingAngiogenesis and VEGF in Cancer

Systemic oxygenation weakens the hypoxia and hypoxia inducible factor 1α-dependent and extracellular adenosine-mediated tumor protection

Open access
Hatfield, Stephen M., Kjaergaard, Jorgen, Lukashev, Dmitriy, Belikoff, Bryan, Schreiber, Taylor H., Sethumadhavan, Shalini, Abbott, Robert, Philbrook, Phaethon +10 more·2014·Journal of Molecular Medicine

Abstract

Unlabelled Intratumoral hypoxia and hypoxia inducible factor-1α (HIF-1-α)-dependent CD39/CD73 ectoenzymes may govern the accumulation of tumor-protecting extracellular adenosine and signaling through A2A adenosine receptors (A2AR) in tumor microenvironments (TME). Here, we explored the conceptually novel motivation to use supplemental oxygen as a treatment to inhibit the hypoxia/HIF-1α-CD39/CD73-driven accumulation of extracellular adenosine in the TME in order to weaken the tumor protection. We report that hyperoxic breathing (60 % O2) decreased the TME hypoxia, as well as levels of HIF-1α and downstream target proteins of HIF-1α in the TME according to proteomic studies in mice. Importantly, oxygenation also downregulated the expression of adenosine-generating ectoenzymes and significantly lowered levels of tumor-protecting extracellular adenosine in the TME. Using supplemental oxygen as a tool in studies of the TME, we also identified FHL-1 as a potentially useful marker for the conversion of hypoxic into normoxic TME. Hyperoxic breathing resulted in the upregulation of antigen-presenting MHC class I molecules on tumor cells and in the better recognition and increased susceptibility to killing by tumor-reactive cytotoxic T cells. Therapeutic breathing of 60 % oxygen resulted in the significant inhibition of growth of established B16.F10 melanoma tumors and prolonged survival of mice. Taken together, the data presented here provide proof-of principle for the therapeutic potential of systemic oxygenation to convert the hypoxic, adenosine-rich and tumor-protecting TME into a normoxic and extracellular adenosine-poor TME that, in turn, may facilitate tumor regression. We propose to explore the combination of supplemental oxygen with existing immunotherapies of cancer.Key messages Oxygenation decreases levels of tumor protecting hypoxia. Oxygenation decreases levels of tumor protecting extracellular adenosine. Oxygenation decreases expression of HIF-1alpha dependent tumor-protecting proteins. Oxygenation increases MHC class I expression and enables tumor regression.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00109-014-1189-3

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 37 · Cited by 211

Authors
Hatfield, S. M., Kjaergaard, J., Lukashev, D., Belikoff, B., Schreiber, T. H., Sethumadhavan, S., Abbott, R., Philbrook, P., Thayer, M., Shujia, D., Rodig, S., Kutok, J. L., Ren, J., Ohta, A., Podack, E. R., Karger, B., Jackson, E. K., & Sitkovsky, M.
Affiliations
  • Northeastern University (US)
  • University of Miami (US)
  • Brigham and Women's Hospital (US)
  • University of Pittsburgh (US)
Corresponding author
  • Hatfield, Stephen M.
  • Sitkovsky, Michail
Venue
Journal of Molecular Medicine
Published
2014-08-15
Volume
92
Issue
12
Pages
1283-1292
ISSN
  • 0946-2716 (ISSN-L)
  • 1432-1440
OpenAlex
W2054661897
Cited by
211
References
37
Citations by year
2026: 13 · 2025: 21 · 2024: 16 · 2023: 15 · 2022: 25 · 2021: 27 · 2020: 24 · 2019: 17 · 2018: 15 · 2017: 16 · 2016: 11 · 2015: 10 · 2014: 1
FWCI
4.06
Type
journal article
Language
en
Open access
Locations
  • Journal of Molecular Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health
  • National Cancer Institute (R01CA112561, R01CA111985)
  • National Institute of General Medical Sciences (R01GM097320)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK079307)
  • National Center for Complementary and Integrative Health (R21AT002788)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Keywords
systemic oxygenation, supplemental oxygen, tumor hypoxia, hypoxia-inducible factor-1α, extracellular adenosine, adenosine A2A receptor, tumor microenvironment, FHL1, MHC class I expression, tumor immunogenicity, cytotoxic T lymphocytes, B16F10 melanoma, cancer immunotherapy
MeSH terms
Adenosine, Animals, Hypoxia, Female, Mice, Inbred C57BL, Neoplasms, Oxygen, Cell Hypoxia, Cell Line, Tumor, Hypoxia-Inducible Factor 1, alpha Subunit, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review